COCO Form 4: Director Sadowsky Disposes 3,900 Shares Under 10b5-1 Plan
Rhea-AI Filing Summary
Kenneth Sadowsky, a director of Vita Coco Company, Inc., sold 3,900 shares of common stock on 09/17/2025 under a Rule 10b5-1 trading plan at a weighted average price of $40.034 (individual trade prices ranged from $39.65 to $40.22). After the sale he beneficially owned 623,866 shares. The filing also discloses a fully vested, currently exercisable non-qualified stock option covering 27,300 underlying shares with a $10.178 exercise price. The Form 4 was filed by an attorney-in-fact on behalf of the reporting person and identifies the sale as pre-arranged under Rule 10b5-1.
Positive
- Sale executed under a Rule 10b5-1 plan, indicating a pre-arranged trade rather than opportunistic insider timing.
- Reporting person retains substantial ownership with 623,866 shares beneficially owned after the sale.
- Holds fully vested, exercisable options for 27,300 underlying shares at a $10.178 exercise price.
Negative
- None.
Insights
TL;DR: Routine, pre-planned insider sale; maintains substantial ongoing ownership and holds vested options.
The sale of 3,900 shares pursuant to a Rule 10b5-1 plan signals a pre-arranged disposition rather than an opportunistic, ad hoc insider trade. The reporting person remains a significant shareholder with 623,866 shares post-transaction, which supports continuity of insider alignment with shareholders. Disclosure of a fully vested, exercisable option for 27,300 shares at a $10.178 strike highlights future potential for share issuance if exercised, but the filing provides no exercise or expiration dates beyond the vesting/exercisability statement. Overall, governance disclosure is standard and compliant.
TL;DR: Small-sized sale using a Rule 10b5-1 plan; no material change to ownership or control.
The transaction size (3,900 shares) is small relative to the remaining beneficial ownership (623,866 shares) and was executed under a Rule 10b5-1 plan, reducing concerns about opportunistic timing. The weighted average sale price reported is $40.034 with individual trades between $39.65 and $40.22. The disclosure of 27,300 underlying shares subject to fully vested, exercisable options at a $10.178 strike is relevant for potential dilution analysis, but the filing does not indicate imminent exercises. From a market-impact perspective, this Form 4 reflects routine insider liquidity rather than a material event.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock | 3,900 | $40.034 | $156K |
| holding | Non-Qualified Stock Option (right to buy) | -- | -- | -- |
Footnotes (1)
- The sales of shares of common stock reported were effected pursuant to a Rule 10b5-1 trading plan. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $39.65 to $40.22, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. The stock option is fully vested and currently exercisable.
